810 research outputs found
Degrees in random -ary hooking networks
The theme in this paper is a composition of random graphs and P\'olya urns.
The random graphs are generated through a small structure called the seed. Via
P\'olya urns, we study the asymptotic degree structure in a random -ary
hooking network and identify strong laws. We further upgrade the result to
second-order asymptotics in the form of multivariate Gaussian limit laws. We
give a few concrete examples and explore some properties with a full
representation of the Gaussian limit in each case. The asymptotic covariance
matrix associated with the P\'olya urn is obtained by a new method that
originated in this paper and is reported in [25].Comment: 21 pages, 5 figure
Directed transport as a mechanism for protein folding in vivo
We propose a model for protein folding in vivo based on a Brownian-ratchet
mechanism in the multidimensional energy landscape space. The device is able to
produce directed transport taking advantage of the assumed intrinsic asymmetric
properties of the proteins and employing the consumption of energy provided by
an external source. Through such a directed transport phenomenon, the
polypeptide finds the native state starting from any initial state in the
energy landscape with great efficacy and robustness, even in the presence of
different type of obstacles. This model solves Levinthal's paradox without
requiring biased transition probabilities but at the expense of opening the
system to an external field.Comment: 16 pages, 7 figure
Graceful numbers
We construct a labeled graph D(n) that reflects the structure of divisors of a given natural number n. We define the concept of graceful numbers in terms of this associated graph and find the general form of such a number. As a consequence, we determine which graceful numbers are perfect
on degrees of end nodes and cut nodes in fuzzy graphs,
Abstract. The notion of strong arcs in a fuzzy graph was introduced by Bhutani and Rosenfeld i
Recommended from our members
The programming of sequences of saccades
Saccadic eye movements move the high-resolution fovea to point at regions of interest. Saccades can only be generated serially (i.e., one at a time). However, what remains unclear is the extent to which saccades are programmed in parallel (i.e., a series of such moments can be planned together) and how far ahead such planning occurs. In the current experiment, we investigate this issue with a saccade contingent preview paradigm. Participants were asked to execute saccadic eye movements in response to seven small circles presented on a screen. The extent to which participants were given prior information about target locations was varied on a trial-by-trial basis: participants were aware of the location of the next target only, the next three, five, or all seven targets. The addition of new targets to the display was made during the saccade to the next target in the sequence. The overall time taken to complete the sequence was decreased as more targets were available up to all seven targets. This was a result of a reduction in the number of saccades being executed and a reduction in their saccade latencies. Surprisingly, these results suggest that, when faced with a demand to saccade to a large number of target locations, saccade preparation about all target locations is carried out in paralle
LORNOXICAM: A REVIEW OF ITS THERAPEUTIC POTENTIAL IN DIFFERENT CLINICAL STUDIES
Lornoxicam is a member of the oxicam group of nonsteroidal antiinflammatory drugs (NSAIDs), producing analgesic and antipyretic effects  through the non-selective inhibition of cyclo-oxygenase-1 and -2. Besides its inhibitory effect on COX1 and COX-2 peripheral receptors, is also increases endogenous dinorphin and beta-endorphin levels promoting central analgesic and anti-inflammatory effects. Recently, lornoxicam has been introduced in Indian market in oral, intravenous and intramuscular formulations.  Lornoxicam is completely absorbed after oral administration, reaching peak plasma concentrations of 280 mg/L within 2.5 hours after a 4 mg dose.  After intramuscular injection maximum plasma concentrations are achieved after approximately 20-25 minutes. Lornoxicam is extensively metabolished in liver by cytochrome P4502DC9 to inactive metabolite 5’-hydroxy-lornoxicam. The mean elimination half life is 3 to 4 hours. There is plenty of literature available on the effect of lornoxicam on chronic and acute pain management. These preliminary finding require confirmation in further comparative studies. Key words:- lornoxicam, analgesic, anti inflammatory drugs
Governing stem cell therapy in India: regulatory vacuum or jurisdictional ambiguity?
Stem cell treatments are being offered in Indian clinics although preclinical evidence of their efficacy and safety is lacking. This is attributed to a governance vacuum created by the lack of legally binding research guidelines. By contrast, this paper highlights jurisdictional ambiguities arising from trying to regulate stem cell therapy under the auspices of research guidelines when treatments are offered in a private market disconnected from clinical trials. While statutory laws have been strengthened in 2014, prospects for their implementation remain weak, given embedded challenges of putting healthcare laws and professional codes into practice. Finally, attending to the capacities of consumer law and civil society activism to remedy the problem of unregulated treatments, the paper finds that the very definition of a governance vacuum needs to be reframed to clarify whose rights to health care are threatened by the proliferation of commercial treatments and individualized negligence-based remedies for grievances
- …